Sangamo Therapeutics (SGMOQ) Total Non-Current Liabilities (2013 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Total Non-Current Liabilities of $73.4 million for Q4 2025, down 5.77% year-over-year from $77.9 million in Q4 2024, and down 9.81% quarter-over-quarter from $81.4 million in Q3 2025.
Sangamo Therapeutics (SGMOQ) Total Non-Current Liabilities (2013 - 2025) Analysis & Trends
Sangamo Therapeutics' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $73.4 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities fell 5.77% year-over-year to $73.4 million; the TTM figure through Dec 2025 stood at $73.4 million (down 5.77% YoY), while the FY2025 annual figure was $73.4 million, down 5.77% from the prior year.
- Total Non-Current Liabilities for Q4 2025 stood at $73.4 million, down from $81.4 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $400.4 million in Q1 2021, with the low at $68.1 million in Q2 2024.
- The 5-year median for Total Non-Current Liabilities is $86.8 million (2023), against an average of $180.6 million.
- The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities surged 117.66% in 2021, then slumped 70.56% in 2023.
- Sangamo Therapeutics' Total Non-Current Liabilities stood at $345.4 million in 2021, then decreased by 22.88% to $266.3 million in 2022, then slumped by 69.5% to $81.2 million in 2023, then retreated by 4.08% to $77.9 million in 2024, then slipped by 5.77% to $73.4 million in 2025.
- Business Quant data shows SGMOQ's Total Non-Current Liabilities at $73.4 million in Q4 2025, $81.4 million in Q3 2025, and $77.0 million in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73.43 Mn |
| Sep 30, 2025 | 81.42 Mn |
| Jun 30, 2025 | 76.99 Mn |
| Mar 31, 2025 | 80.33 Mn |
| Dec 31, 2024 | 77.93 Mn |
| Sep 30, 2024 | 70.89 Mn |
| Jun 30, 2024 | 68.10 Mn |
| Mar 31, 2024 | 71.06 Mn |
| Dec 31, 2023 | 81.25 Mn |
| Sep 30, 2023 | 83.46 Mn |
| Jun 30, 2023 | 90.17 Mn |
| Mar 31, 2023 | 103.73 Mn |
| Dec 31, 2022 | 266.34 Mn |
| Sep 30, 2022 | 283.45 Mn |
| Jun 30, 2022 | 297.56 Mn |
| Mar 31, 2022 | 318.55 Mn |
| Dec 31, 2021 | 345.36 Mn |
| Sep 30, 2021 | 358.75 Mn |
| Jun 30, 2021 | 382.48 Mn |
| Mar 31, 2021 | 400.45 Mn |